The clinical utility of NT-proBNP in AF extends from predicting the incidence of AF in the general population [36,37,38] with a recommended cut-off value of 124–125 ng/L for at-risk healthy individuals [39,40,41], to predicting AF morbidity and mortality [19,42] and disease progression [20]. Here, NPPB is linked to atrial fibrillation.